The next generation of PDE4 inhibitors
- 18 July 2001
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 5 (4) , 432-438
- https://doi.org/10.1016/s1367-5931(00)00224-6
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Genomic organization of the human phosphodiesterase PDE11A geneEuropean Journal of Biochemistry, 2001
- Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitorsImmunopharmacology, 2000
- Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functionsCurrent Opinion in Cell Biology, 2000
- New phosphodiesterase inhibitors as therapeutics for the treatment of chronic lung diseaseCurrent Opinion in Pulmonary Medicine, 2000
- ArifloTM(SB 207499), a Second Generation Phosphodiesterase 4 Inhibitor for the Treatment of Asthma and COPD: from Concept to ClinicPulmonary Pharmacology & Therapeutics, 1999
- Emesis induced by inhibitors of type IV cyclic nucleotide phosphodiesterase (PDE IV) in the ferretNeuropharmacology, 1999
- The Molecular Biology of Cyclic Nucleotide PhosphodiesterasesProgress in Nucleic Acid Research and Molecular Biology, 1999
- Phosphodiesterase 4 (PDE4) inhibitors in asthma and chronic obstructive pulmonary disease (COPD)Published by Springer Nature ,1999
- Phosphodiesterase IsozymesAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Type 4 Phosphodiesterase Inhibitors Have Clinical and In Vitro Anti-inflammatory Effects in Atopic DermatitisJournal of Investigative Dermatology, 1996